Alnylam Pharmaceuticals, Inc. (BVMF:A1LN34)
Brazil
· Delayed Price · Currency is BRL 124.80
+3.20 (2.63%)
Last updated: Dec 3, 2025, 5:00 PM GMT-3
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 327.59 billion as of December 5, 2025. Its market cap has increased by 88.01% in one year.
Market Cap
327.59B
Enterprise Value
327.86B
Revenue
17.11B
Ranking
n/a
PE Ratio
1,410.97
Stock Price
124.80
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 361.82M to 327.59B, an increase of 90,440.73%. That is a compound annual growth rate of 37.18%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.31B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.32B |